Search research articles
Contact Us
Filters
Showing results (151-160 of 203) with videos related to
Page
of 21
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 16, 2016
Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2-Associated Vestibular Schwannomas
Jaishri O Blakeley, Xiaobu Ye, Dan G Duda, et al.
Pediatric Blood & Cancer
|
February 24, 2015
Phase II/III trial of a pre-transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: a report from the Children's Oncology Group
Elliot Stieglitz, Ashley F Ward, Robert B Gerbing, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2016
Sequence-Specific Pharmacokinetic and Pharmacodynamic Phase I/Ib Study of Olaparib Tablets and Carboplatin in Women's Cancer
Jung-Min Lee, Cody J Peer, Minshu Yu, et al.
Plos Genetics
|
October 21, 2014
Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis
Alexander Pemov, Heejong Sung, Paula L Hyland, et al.
Pediatric Blood & Cancer
|
August 12, 2021
Phase 1 study of sorafenib and irinotecan in pediatric patients with relapsed or refractory solid tumors
Holly J Meany, Brigitte C Widemann, Pamela S Hinds, et al.
Sarcoma
|
August 21, 2019
Targeting Sporadic and Neurofibromatosis Type 1 (NF1) Related Refractory Malignant Peripheral Nerve Sheath Tumors (MPNST) in a Phase II Study of Everolimus in Combination with Bevacizumab (SARC016)
Brigitte C Widemann, Yao Lu, Denise Reinke, et al.
Ophthalmology
|
October 11, 2025
Long-term Ocular Safety in Children Treated with Mitogen-Activated Protein Kinase Pathway Inhibitor Therapy
Robert A Avery, Andrea M Gross, Chantal Cousineau-Krieger, et al.
Current Oncology (Toronto, Ont.)
|
December 13, 2021
Tumor Doubling Time Using CT Volumetric Segmentation in Metastatic Adrenocortical Carcinoma
Sarah N Fuller, Ahmad Shafiei, David J Venzon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 1, 2017
Outcomes of Children and Adolescents with Advanced Hereditary Medullary Thyroid Carcinoma Treated with Vandetanib
Ira L Kraft, Srivandana Akshintala, Yuelin Zhu, et al.
Pediatric Blood & Cancer
|
April 23, 2014
Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas
Brigitte C Widemann, Dusica Babovic-Vuksanovic, Eva Dombi, et al.
Page
of 21
Search research articles
Search
Showing results (151-160 of 203) with videos related to
Sort By:
Page
of 21
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 16, 2016
Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2-Associated Vestibular Schwannomas
Jaishri O Blakeley, Xiaobu Ye, Dan G Duda, et al.
Pediatric Blood & Cancer
|
February 24, 2015
Phase II/III trial of a pre-transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: a report from the Children's Oncology Group
Elliot Stieglitz, Ashley F Ward, Robert B Gerbing, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2016
Sequence-Specific Pharmacokinetic and Pharmacodynamic Phase I/Ib Study of Olaparib Tablets and Carboplatin in Women's Cancer
Jung-Min Lee, Cody J Peer, Minshu Yu, et al.
Plos Genetics
|
October 21, 2014
Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis
Alexander Pemov, Heejong Sung, Paula L Hyland, et al.
Pediatric Blood & Cancer
|
August 12, 2021
Phase 1 study of sorafenib and irinotecan in pediatric patients with relapsed or refractory solid tumors
Holly J Meany, Brigitte C Widemann, Pamela S Hinds, et al.
Sarcoma
|
August 21, 2019
Targeting Sporadic and Neurofibromatosis Type 1 (NF1) Related Refractory Malignant Peripheral Nerve Sheath Tumors (MPNST) in a Phase II Study of Everolimus in Combination with Bevacizumab (SARC016)
Brigitte C Widemann, Yao Lu, Denise Reinke, et al.
Ophthalmology
|
October 11, 2025
Long-term Ocular Safety in Children Treated with Mitogen-Activated Protein Kinase Pathway Inhibitor Therapy
Robert A Avery, Andrea M Gross, Chantal Cousineau-Krieger, et al.
Current Oncology (Toronto, Ont.)
|
December 13, 2021
Tumor Doubling Time Using CT Volumetric Segmentation in Metastatic Adrenocortical Carcinoma
Sarah N Fuller, Ahmad Shafiei, David J Venzon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 1, 2017
Outcomes of Children and Adolescents with Advanced Hereditary Medullary Thyroid Carcinoma Treated with Vandetanib
Ira L Kraft, Srivandana Akshintala, Yuelin Zhu, et al.
Pediatric Blood & Cancer
|
April 23, 2014
Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas
Brigitte C Widemann, Dusica Babovic-Vuksanovic, Eva Dombi, et al.
Page
of 21